Cumberland Pharmaceuticals (Cumberland Pharmaceuticals) Days Payable : 741.21 (As of Dec. 2023)

View and export this data going back to 2009. Start your Free Trial

What is Cumberland Pharmaceuticals Days Payable?

Cumberland Pharmaceuticals's average Accounts Payable for the three months ended in Dec. 2023 was $12.43 Mil. Cumberland Pharmaceuticals's Cost of Goods Sold for the three months ended in Dec. 2023 was $1.53 Mil. Hence, Cumberland Pharmaceuticals's Days Payable for the three months ended in Dec. 2023 was 741.21.

The historical rank and industry rank for Cumberland Pharmaceuticals's Days Payable or its related term are showing as below:

CPIX' s Days Payable Range Over the Past 10 Years
Min: 190.66 Med: 449.27 Max: 747.72
Current: 695.46

During the past 13 years, Cumberland Pharmaceuticals's highest Days Payable was 747.72. The lowest was 190.66. And the median was 449.27.

CPIX's Days Payable is ranked better than
95.39% of 977 companies
in the Drug Manufacturers industry
Industry Median: 86.23 vs CPIX: 695.46

Cumberland Pharmaceuticals's Days Payable increased from Dec. 2022 (384.31) to Dec. 2023 (741.21). It may suggest that Cumberland Pharmaceuticals delayed paying its suppliers.

Cumberland Pharmaceuticals Days Payable Historical Data

The historical data trend for Cumberland Pharmaceuticals's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cumberland Pharmaceuticals Days Payable Chart

Cumberland Pharmaceuticals Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Payable

Get a 7-Day Free Trial

518.58

493.32

477.16

409.47

747.72

Cumberland Pharmaceuticals Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Days Payable	Get a 7-Day Free Trial															384.31	803.85	663.95	561.40	741.21

Competitive Comparison of Cumberland Pharmaceuticals's Days Payable

For the Drug Manufacturers - Specialty & Generic subindustry, Cumberland Pharmaceuticals's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cumberland Pharmaceuticals's Days Payable Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cumberland Pharmaceuticals's Days Payable distribution charts can be found below:

* The bar in red indicates where Cumberland Pharmaceuticals's Days Payable falls into.

Cumberland Pharmaceuticals Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Cumberland Pharmaceuticals's Days Payable for the fiscal year that ended in Dec. 2023 is calculated as

	Days Payable (A: Dec. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Dec. 2022 )	+	Accounts Payable (A: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2023 )	*	Days in Period
=	( (10.819	+	14.038)	/	2 )	/	6.067	*	365
=	12.4285					/	6.067	*	365
=	747.72

Cumberland Pharmaceuticals's Days Payable for the quarter that ended in Dec. 2023 is calculated as:

	Days Payable (Q: Dec. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Sep. 2023 )	+	Accounts Payable (Q: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (Q: Dec. 2023 )	*	Days in Period
=	( (10.818	+	14.038)	/	2 )	/	1.53	*	365 / 4
=	12.428					/	1.53	*	365 / 4
=	741.21

Cumberland Pharmaceuticals Days Payable Related Terms

Thank you for viewing the detailed overview of Cumberland Pharmaceuticals's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Cumberland Pharmaceuticals (Cumberland Pharmaceuticals) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cumberland Pharmaceuticals Inc (NAS:CPIX) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

N/A

Address

1600 West End Avenue, Suite 1300, Nashville, TN, USA, 37203

Website

https://www.cumberlandpharma.com

Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The company's primary target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The company promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. The company's revenue is derived from the product sales of FDA-approved pharmaceutical brands. Its brands include Acetadote, Caldolor, Kristalose, Omeclamox, RediTrex, Sancuso, Vaprisol and Vibativ.

Executives

Todd M. Anthony	officer: Vice Pres Organizational Dev	1600 WEST END AVENUE, SUITE 1300, NASHVILLE TN 37203
Chris T. Bitterman	officer: Vice Pres Sales & Marketing	1600 WEST END AVENUE, SUITE 1300, NASHVILLE TN 37203
Joseph C Galante	director	111 TENTH AVENUE, SUITE 200, NASHVILLE TN 37203
James Jones	director	2525 WEST END AVE., SUITE 950, NASHVILLE TN 37203
Kenneth Krogulski	director	2525 WEST END AVENUE, SUITE 950, NASHVILLE TN 37203
Caroline Young	director	2525 WEST END AVENUE, SUITE 950, NASHVILLE TN 37203
Brown Martin S Jr	director	850 DIXIE HIGHWAY, LOUISVILLE KY 40210
A J Kazimi	director, 10 percent owner, officer: Chairman and CEO	1207 17TH AVENUE SUITE 103, NASHVILLE TN 37212
Martin E Cearnal	director	31 UPPER MOUNTAIN AVENUE, APARTMENT 2, MONTCLAIR NJ 07042
John M. Hamm	officer: Chief Financial Officer	2525 WEST END AVENUE, SUITE 950, NASHVILLE TN 37203
Gordon R Bernard	officer: Senior Vice President	2525 WEST END AVENUE, SUITE 950, NASHVILLE TN 37203
Joey A Jacobs	director	830 CRESCENT CENTER DRIVE, SUITE 610, FRANKLIN TN 37067
Michael Bonner	officer: Chief Financial Officer	2525 WEST END AVENUE, SUITE 950, NASHVILLE TN 37203
Jonathan Griggs	director	2525 WEST END AVENUE, SUITE 950, NASHVILLE TN 37203
Thomas R Lawrence	director	1880 ELLINGTON WAY, AUBURN AL 36830